Invention Grant
- Patent Title: Substituted quinoxalines as FGFR kinase inhibitors
- Patent Title (中): 取代的喹喔啉作为FGFR激酶抑制剂
-
Application No.: US14354636Application Date: 2012-10-26
-
Publication No.: US09303029B2Publication Date: 2016-04-05
- Inventor: Steven John Woodhead , Christopher William Murray , Valerio Berdini , Gordon Saxty , Gilbert Ebai Besong , Lieven Meerpoel , Olivier Alexis Georges Querolle , Virginie Sophie Poncelet
- Applicant: ASTEX THERAPEUTICS LIMITED
- Applicant Address: GB Cambridge
- Assignee: ASTEX THERAPEUTICS LTD
- Current Assignee: ASTEX THERAPEUTICS LTD
- Current Assignee Address: GB Cambridge
- Agency: Heslin Rothenberg Farley & Mesiti P.C.
- Priority: GB1118654.1 20111028
- International Application: PCT/GB2012/052673 WO 20121026
- International Announcement: WO2013/061081 WO 20130502
- Main IPC: A61K31/498
- IPC: A61K31/498 ; C07D241/42 ; C07D471/04 ; C07D403/12 ; C07D401/14 ; C07D413/14 ; C07D401/04 ; C07D401/06 ; C07D401/12 ; C07D403/04 ; C07D403/06 ; C07D407/04 ; C07D407/14 ; C07D413/04 ; C07D417/04 ; C07D241/44 ; C07D417/12 ; A61K31/4985 ; A61K31/506 ; A61K45/06 ; C07D405/04 ; C07D405/14
Abstract:
The invention relates to new quinoxaline derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
Public/Granted literature
- US20150031669A1 ANTICANCER BENZOPYRAZINES VIA THE INHIBITION OF FGFR KINASES Public/Granted day:2015-01-29
Information query
IPC分类:
